Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP known ✓ | P19971 | 9/20 | 0.38 |
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.35 |
| ▸ | PNP known ✓ | P00491 | 1/20 | 0.33 |
| ▸ | PDE3B known ✓ | Q13370 | 1/20 | 0.33 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.33 |
| ▸ | PARP1 known ✓ | P09874 | 1/20 | 0.30 |
| ▸ | IDH1 | O75874 | 1/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6441859 | 1.00 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1GDA | |
| Hydrochloric Acid SCHEMBL237155 | 1.00 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1GDA | |
| Hydrochloric Acid SCHEMBL4462818 | 0.95 | IDH1 (0.39) | IDH1CSNK2A2CSNK2BCSNK2A1GDA | |
| Hydrochloric Acid SCHEMBL9595531 | 0.95 | IDH1 (0.39) | IDH1CSNK2A2CSNK2BCSNK2A1GDA | |
| SCHEMBL20706 | 0.94 | — | — | |
| Methane SCHEMBL10716051 | 0.89 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1GDA | |
| SCHEMBL15992544 | 0.89 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1GDA | |
| SCHEMBL21647160 | 0.89 | — | — | |
| SCHEMBL38659404 | 0.89 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1GDA | |
| SCHEMBL5386400 | 0.89 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1GDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024016618-A1 | METHOD FOR PREPARING 2-CHLORO-5-METHYLPYRIDINE THROUGH CONTINUOUS FLOW | 江苏瑞祥化工有限公司 | 2024-01-25 | — | — | WO | claimed |
| WO-2023231312-A1 | NANOFILTRATION MEMBRANE PREPARATION METHOD, AND NANOFILTRATION MEMBRANE PREPARED THEREBY | 沃顿科技股份有限公司 | 2023-12-07 | — | — | WO | claimed |
| WO-2023201774-A1 | NEGATIVE ELECTRODE MATERIAL AND PREPARATION METHOD THEREFOR, AND LITHIUM ION BATTERY | 贝特瑞新材料集团股份有限公司 | 2023-10-26 | — | — | WO | claimed |
| CN-111718478-A | Polymer flame retardant and preparation method thereof | 欧阳杰 | 2020-09-29 | — | — | CN | claimed |
| CN-111635514-A | Crosslinked polymer flame retardant and preparation method thereof | 马海社 | 2020-09-08 | — | — | CN | claimed |
| CN-111621161-A | Crosslinked polymer flame retardant and preparation method thereof | 马海社 | 2020-09-04 | — | — | CN | claimed |
| CN-109694123-A | A kind of inorganic high molecular water purifier | 成都巴吉科技有限公司 | 2019-04-30 | — | — | CN | claimed |
| WO-2015004035-A1 | METHOD FOR PREPARATION OF 4-ALKOXY-1,1,1-TRIFLUOROBUT-3-EN-2-ONES FROM TRIFLUOROACETYLACETIC ACID | LONZA LTD (CH) | 2015-01-15 | — | — | WO | claimed |
| CN-103907598-A | Chlorine disinfectant effervescent tablet | LANZHOU INST ANIMAL SCIENCE & VETERINARY PHARMACEUTICS CAAS | 2014-07-09 | — | — | CN | claimed |
| EP-2459531-A2 | SYNTHESIS AND USE OF VILDAGLIPTIN FOR THE PREPARATION OF PHARMACEUTICAL DOSAGE FORMS | KRKA, D.D., Novo Mesto (SI) | 2012-06-06 | — | — | EP | claimed |
| CN-1339408-A | Inorganic high molecular water purifier | WU XINGJIU (CN) | 2002-03-13 | — | — | CN | claimed |
| US-6018044-A | TRIS((ALKYL, SILANE, OLIGOSILOXANE OR POLYSILOXANE)(OXY OR AMINO)CARBONYL-(1,4-PHENYLENE)-AMINO)-S-TRIAZINES HAVING AT LEAST ONE SILICON CONTAINING MOIETY OF GIVEN FORMULA; USE AS UV-B FILTERS IN LIGHT SCREENING COMPOSITIONS | ROCHE VITAMINS INC. (US) | 2000-01-25 | — | — | US | claimed |
| EP-0933376-A2 | Silanyl-triazines as light screening compositions | F. HOFFMANN-LA ROCHE AG (CH) | 1999-08-04 | — | — | EP | claimed |
| US-5602226-A | Method of making multidimensional polyesters | THE BOEING COMPANY (US) | 1997-02-11 | — | — | US | claimed |
| EP-0057382-B1 | PROCESS FOR THE PREPARATION OF VAT DYES FROM THE WASTE PRODUCTS OF THE SYNTHESIS OF NITRO-ANTHRAQUINONE AND ANTHRAQUINONE SULFONIC ACID | BAYER AG (DE) | 1983-12-28 | — | — | EP | claimed |
| US-4353802-A | Semipermeable composite membrane | TEIJIN LIMITED (JP) | 1982-10-12 | — | — | US | claimed |
| US-4302336-A | A CROSSLINKED AMINE-MODIFIED ACRYLIC POLYMER; DESALTING OF BRINES BY REVERSE OSMOSIS | TEIJIN LIMITED (JP) | 1981-11-24 | — | — | US | claimed |
| US-4205128-A | FOR INDUSTRIAL USE | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1980-05-27 | — | — | US | claimed |
| EP-0008945-A2 | Semipermeable composite membrane, process for producing said membrane, and method of desalination using said membrane | TEIJIN LIMITED (JP) | 1980-03-19 | — | — | EP | claimed |
| US-4039538-A | Preparation of tris-(halophenoxy)-sym.-triazines | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1977-08-02 | — | — | US | claimed |